1253-APOLLO11: AI Framework for Precision Lung Oncology

The APOLLO11 consortium is a nationwide Italian network established to advance precision oncology for lung cancer patients through a data-driven research paradigm. By integrating real-world data, medical imaging, and multi-omic biological samples, the project overcomes the limitations of traditional hypothesis-driven studies. The infrastructure utilizes artificial intelligence and federated learning to develop predictive algorithms that help clinicians tailor treatments to individual patients while ensuring data privacy. This decentralized model connects major research "hubs" with smaller "spoke" centers, fostering a collaborative ecosystem that standardizes and harmonizes complex clinical information. Ultimately, the initiative seeks to identify predictive biomarkers for innovative therapies, such as immunotherapy, to optimize patient outcomes and minimize treatment toxicity. At its core, APOLLO11 serves as a comprehensive bio-data repository designed to address unmet clinical needs in the rapidly evolving landscape of cancer care.References:Prelaj A, Provenzano L, Miskovic V, et al. APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer[J]. npj Precision Oncology, 2026.前往小宇宙评论区与主播互动